Compare Amphastar Pharmaceuticals Inc (AMPH) vs MPLX LP (MPLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs MPLX LP — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while MPLX LP trades at $59.35 (market cap $60.12B). The key difference: MPLX LP is far larger — about 69.2× Amphastar Pharmaceuticals Inc's market cap, and MPLX LP pays a 7.26% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | MPLX | |
|---|---|---|
Market Cap | $868.62M | $60.12B |
Sector | Health | Technology |
52-Week High | $30.81 | $60.51 |
52-Week Low | $16.87 | $47.80 |
Enterprise Value | $1.27B | $85.22B |
Dividend Yield | — | 7.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →
